CAM trial breaks new ground

A HERBAL preparation and prescription drug will go head to head in an Australian-first trial designed to set a new evidentiary benchmark for complementary and alternative medicine (CAM).

The trial will pit Iberogast, a liquid formulation of nine herbs, against the proton pump inhibitor (PPI) esomeprazole (Nexium) in patients with functional dyspepsia.